TC BioPharm (Holdings) plc
TCBPDelisted Aug 8, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001872812
TC BioPharm (Holdings) plc was delisted on Aug 8, 2025; its insiders filed their last Form 4 on Jan 11, 2023; 12 institutions reported holding it in 13F filings for Q3 2023, worth $179.6K in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding TC BioPharm (Holdings) plc changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 5 | 2 | −3 |
| Shares | 507.1K | 84.1K | −423.0K (−83.4%) |
| Value | $141.0K | $323.8K | +$182.8K (+129.6%) |
New holders (2)
Institutions that held TC BioPharm (Holdings) plc at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 82,712 | $318.4K | 0.01% |
| UBS Group AG | 1,392 | $5.36K | 0.00% |
Sold out (5)
Institutions that held TC BioPharm (Holdings) plc at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Legal & General Group Plc | 207,258 | $58.0K |
| Renaissance Technologies LLC | 146,400 | $41.0K |
| Virtu Financial LLC | 130,005 | $35.0K |
| Warberg Asset Management LLC | 12,500 | $4.00K |
| Marshall Financial Group LLC | 10,900 | $3.00K |